Huge drug cost disparities seen in health overhaul

by Ricardo Alonso-Zaldivar

(AP)—Consumer alert: If you or someone you know needs costly medications and you're hoping President Barack Obama's health care law will meet the need, you may be in for a surprise.

Where you live could make a huge difference in what you'll pay.

To keep premiums low, some states are allowing insurers to charge patients a large share of the cost for expensive medications for cancer and other serious conditions.

These "specialty drugs" cost thousands of dollars a month.

In California, the patient's share would be up to 30 percent. New York is doing it differently, setting flat copayments for all medications. The highest is $70.

Critics fear most states will follow California's lead.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Obama health law a good deal for states

Nov 26, 2012

(AP)—A new report says states can receive more than $9 in federal money for every dollar they spend to cover low-income residents under President Barack Obama's health care law.

Study: Health overhaul to raise claims cost 32 pct

Mar 26, 2013

(AP)—The nation's leading group of financial risk analysts says medical claims costs—the biggest driver of insurance premiums—will jump an average 32 percent for individual policies under President Barack Obama's health ...

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.